- Home
- CTSO vs PRT Comparison
CTSO vs PRT Comparison
Compare CTSO & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- PRT
- Stock Information
- Founded
- CTSO 1997
- PRT 2017
- Country
- CTSO United States
- PRT United States
- Employees
- CTSO N/A
- PRT N/A
- Industry
- CTSO Medical/Dental Instruments
- PRT Oil & Gas Production
- Sector
- CTSO Health Care
- PRT Energy
- Exchange
- CTSO Nasdaq
- PRT Nasdaq
- Market Cap
- CTSO 68.2M
- PRT N/A
- IPO Year
- CTSO N/A
- PRT N/A
- Fundamental
- Price
- CTSO $0.87
- PRT $3.82
- Analyst Decision
- CTSO Strong Buy
- PRT
- Analyst Count
- CTSO 3
- PRT 0
- Target Price
- CTSO $4.67
- PRT N/A
- AVG Volume (30 Days)
- CTSO 138.7K
- PRT 29.0K
- Earning Date
- CTSO 05-14-2025
- PRT 05-20-2025
- Dividend Yield
- CTSO N/A
- PRT 11.67%
- EPS Growth
- CTSO N/A
- PRT N/A
- EPS
- CTSO N/A
- PRT 0.42
- Revenue
- CTSO $35,594,520.00
- PRT $6,018,264.00
- Revenue This Year
- CTSO $18.72
- PRT N/A
- Revenue Next Year
- CTSO $19.75
- PRT N/A
- P/E Ratio
- CTSO N/A
- PRT $8.91
- Revenue Growth
- CTSO 14.51
- PRT N/A
- 52 Week Low
- CTSO $0.70
- PRT $3.26
- 52 Week High
- CTSO $1.61
- PRT $4.63
- Technical
- Relative Strength Index (RSI)
- CTSO 33.89
- PRT 45.44
- Support Level
- CTSO $0.87
- PRT $3.73
- Resistance Level
- CTSO $1.16
- PRT $3.87
- Average True Range (ATR)
- CTSO 0.07
- PRT 0.11
- MACD
- CTSO -0.02
- PRT -0.00
- Stochastic Oscillator
- CTSO 0.00
- PRT 34.18
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.